Telaprevir pharmacokinetics in a hepatitis C virus infected patient on haemodialysis.

Subjects

Subjects :

Hepacivirus drug effects
Hepatitis C virology
Humans
Kidney Failure, Chronic therapy
Male
Middle Aged
Oligopeptides pharmacokinetics
Oligopeptides therapeutic use
Protease Inhibitors pharmacokinetics
Protease Inhibitors therapeutic use
Hepatitis C drug therapy
Oligopeptides blood
Protease Inhibitors blood
Renal Dialysis

Details

Language :

English

ISSN :

1873-5967

Volume :

60

Issue :

4

Database :

MEDLINE

Journal :

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

Publication Type :

Report

Accession number :

24929751

Full Text :

https://doi.org/10.1016/j.jcv.2014.05.008